alovudine has been researched along with 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, D; Chen, LC; Chou, TC; Huang, JT; Kim, MH; Matulic-Adamic, J; Wang, LB; Warshaw, JA; Watanabe, KA; Zhu, QY | 1 |
| Balzarini, J; De Clercq, E; Herdewijn, P; Pauwels, R; Van Aerschot, A | 1 |
| Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV | 1 |
3 other study(ies) available for alovudine and 1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine
| Article | Year |
|---|---|
Fluorinated sugar analogues of potential anti-HIV-1 nucleosides.
Topics: Animals; Antiviral Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Dideoxynucleosides; HIV-1; Humans; Mink; Structure-Activity Relationship | 1991 |
3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analogues.
Topics: Antiviral Agents; Chemical Phenomena; Chemistry; Dideoxynucleosides; HIV-1 | 1989 |
HIV-1 reverse transcriptase inhibitor design using artificial neural networks.
Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1994 |